Home | About PM | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |  Login 
Pharmacognosy Magazine
Search Article 
Advanced search 

  Table of Contents  
Year : 2022  |  Volume : 18  |  Issue : 78  |  Page : 458-462  

Quercetin of Potentilla bifurca 3-Glycosylation Substitution Impact the Inhibitory Activity on α-glucosidase

1 Qinghai Normal University, College of Life Science, Qinghai Normal University, Xining 810008, Qinghai, China
2 Qinghai Normal University, College of Life Science, Qinghai Normal University, Xining 810008; Academy of Plateau Science and Sustainability, Qinghai Normal University, Xining 810016, Qinghai, China

Date of Submission11-Oct-2021
Date of Decision24-Mar-2022
Date of Acceptance06-Apr-2022
Date of Web Publication07-Jul-2022

Correspondence Address:
Likuan Liu
College of Life Science, Qinghai, Qinghai Normal University, Xining 810008
Yang Zeng
College of Life Science, Academy of Plateau Science and Sustainability, Qinghai, Qinghai Normal University, Xining 810008
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/pm.pm_522_21

Rights and Permissions

Background: Inhibition of glycosidase activity is an effective diabetes therapy and prevention strategy. In this study, we aimed to explore the effects of quercetin and its derivatives extracted from Potentilla bifurca on α-glycosidaseinhibited vitality. Materials and Methods: Various chromatographic methods and separation techniques were used to separate quercetin and quercetin derivatives. An enzyme reaction system was established to determine the inhibitory activity of P. bifurca compounds against α-glucosidase and the type of enzyme inhibitor reaction. Results: The changes in activity between quercetin and its derivatives is observed in the following areas: (1) The action of flavonoids is expected to be influenced by the substituents of different molecules. Glycosylation of quercetin reduces its hypoglycemic effect, and the molecule created after adding penta-glycoside is larger than that formed after adding hexa-glycoside. (2) The acylated drugs can possibly reduce their activity. Conclusion: P. bifurca has been shown to inhibit glycosidase activity, making it effective in diabetes treatment.

Keywords: α-glycosidase, derivatives, diabetes, P. bifurca, quercetin

How to cite this article:
Qu X, Li J, Yan P, Wang G, Liu W, Zeng Y, Liu L. Quercetin of Potentilla bifurca 3-Glycosylation Substitution Impact the Inhibitory Activity on α-glucosidase. Phcog Mag 2022;18:458-62

How to cite this URL:
Qu X, Li J, Yan P, Wang G, Liu W, Zeng Y, Liu L. Quercetin of Potentilla bifurca 3-Glycosylation Substitution Impact the Inhibitory Activity on α-glucosidase. Phcog Mag [serial online] 2022 [cited 2022 Aug 15];18:458-62. Available from: http://www.phcog.com/text.asp?2022/18/78/458/350123


  • At present, there are few studies on the Potentilla bifurca, and the pharmacological value of Potentilla bifurca needs to be explored. The inhibitory activity and type of α-glucosidase of the Potentilla bifurca compounds were used to explore experiments, and the difference in activity of each compound due to the structure was compared. It proves the potential value of Potentilla bifurca in the treatment of type 2 diabetes

Abbreviations used: AG: α-glucosidase; PNPG: p-Nitrophenyl α-D-glucopyranoside; QC3G: Quercetin- 3-O-β-D-glucopyranoside; QC3X: Quercetin-3-O-β-D-xylose; QC3GP: Quercetin- 3-O-(6''-O-trans-p-coumaroyl)-β-D-glucoside; QC: Quercetin.

   Introduction Top

Diabetes mellitus (DM) is related to a group of metabolic disorders characterized by high blood glucose levels, one of the major global public health problems.[1] The latest available statistics from the International Diabetes Federation reveal that 63 million people had DM worldwide in 2019 and this number is expected to be 700 million by 2045.[2] Glycosidases, which as some of the most specific and proficient catalysts, have gained prominence.[3] Some research suggests that inhibition of the activity of glycosidase is an effective method for the treatment and prevention of diabetes.[4] The α-glycosidase enzyme, also known as a small intestinal digestive enzyme, is one of the main metabolic enzymes in the body. It can quickly degrade dietary starches, leading to a quick increase in blood glucose levels.[5] Inhibition of α-glucosidase delays the digestion and absorption of carbohydrates, resulting in a hypoglycemic effect by controlling postprandial hyperglycemia.[6] The filtering strategy based on α-glucosidase inhibition has been widely applied in the discovery of anti-diabetic drugs.[7] Therefore, developing efficient inhibitors is very important to prevent diabetic complications.[8]

Natural α-glucosidase inhibitor (AGI) is considered an effective drug to treat type 2 diabetes (T2DM). At present, researchers have screened out several AGIs from natural sources. For example, the triterpenoids from Actinidia arguta that contained phenylpropanoid constituent unit showed inhibitory activity on α-glucosidase.[6] The anthocyanins from the fruits of the Cinnamomum camphora tree inhibit α-glucosidase.[9] Polyphenolic fraction derived from citrus has been confirmed to have an anti-glycation effect and has inhibitory activity on the α-glycosidase.[10]

Potentilla bifurca (Potentilla bifurca var. humilior) is a variety of Potentilla in Rosaceae. A genus of ≥500 species worldwide, it has annual or perennial shrubs or herbs with a large distribution in northern temperate regions.[11] The plant is short and is scattered on the surface. It is distributed in Qinghai, Inner Mongolia, Shanxi, Ningxia, Xinjiang, and Tibet in China. It is common in hillside grasslands, river beach sandy lands, and arid grasslands at 2300–4500 m above sea level. Quercetin and its derivatives from P. bifurca were studied to discuss the difference of activity of α- glucosidase in four compounds.

   Materials and Methods Top

Extraction of four compounds

The four compounds were developed by following these steps: The powdered and dried P. bifurca was extracted with petroleum ether and ethyl acetate at room temperature. With 100% methanol at 65°C for three times, the compounds were separated by chromatography using Sephadex LH-20, MCI-gel, and RP-18. Various chromatographic methods and separation techniques were used to separate quercetin and its derivatives.

α-glucosidase inhibitory activity assay

The α-glucosidase activity was assayed using 100 μL PBS buffer (Beijing Solarbio Science & Technology Co., Ltd.), 20 μL sample, 20 μL AG (0.05 U·mL-1, SigmaAldrich, USA), and 20 μL PNPG (8.92 × 10-3 mol·L-1, Sigma, USA) was used as substrates. Further, the enzyme control well was assayed using 120 μL PBS buffer, 20 μL AG (0.05 U·mL-1), and 20 μL PNPG (8.92 × 10-3 mol·L-1) was used as substrates. The color of the sample and the substrate affects the measurement results. To eliminate these effects, the sample control group (with 140 μL PBS buffer, and 20 uL sample) and the substrate control group (with 140 μL PBS buffer, and 20 μL PNPG) were both assayed. The whole enzymatic reaction was performed at 37°C for 30 min, and the absorption at 400 nm was monitored on a microplate spectrophotometer (Bio-Rad Laboratories, China). Each group was tested three times at the same time, the inhibition rate was calculated according to the formula, and the average value was taken for analysis.

where Y1 and Y2 denote the original enzyme activity and the enzyme activity after adding sample; respectively, Y3 and Y4 represent the PNPG background and sample background.

α-glucosidase inhibitory type determination

The enzyme reaction was performed under the abovementioned reaction conditions with inhibitors of various concentrations. The substrate (0.1245 mg·mL-1) was diluted to different concentrations of 0.0249 mg·mL-1, 0.0124 mg·mL-1, 0.0083 mg·mL-1, and 0.0062 mg·mL-1. According to reactions with compounds of different concentrations, the reaction rates were calculated. Inhibition types for the inhibitors were determined by Lineweaver–Burk plots.

Statistical analysis

IC50 was calculated and analyzed using statistical software, SPSS 17.0, the inhibition rate curve was made using Origin 9.1 package, and the double reciprocal curve was made by Microsoft Excel.

   Results Top

Separation and identification of chemical components

[Figure 1] shows the structure of the four compounds. The characteristics of the compounds are identified as follows:
Figure 1: The structure of four compounds

Click here to view

Quercetin-3-O-β-D-glucopyranoside (QC3G), yellow powder. 1H NMR (500 MHz, CD3OD) δ7.73 (1H, d, J = 1.8 Hz, H-2'), 7.68 (1H, dd, J = 8.7, 1.8 Hz, H-6'), 7.27 (1H, d, J = 8.7 Hz, H-5'), 6.36 (1H, d, J = 1.9 Hz, H-8), 6.16 (1H, d, J = 2.0 Hz, H-6), 4.91 (1H, s, H-1''), 3.30 ~3.49 (m, Glc-H2, 3, 4, 5), 3.93 (1H, dd, J = 2.0, 12.1 Hz, Glc-H6α), 3.73 (1H, dd, J = 5.4, 12.1 Hz, Glc-H6β). 13C NMR (500 MHz, CD3OD):δ 158.2 (C-2), 137.9 (C-3), 177.4 (C-4), 162.5 (C-5), 99.3 (C-6), 165.7 (C-7), 94.5 (C-8), 148.1 (C-9), 104.6 (C-10), 121.3 (C-1'), 116.5 (C-2'), 146.8 (C-3'), 147.8 (C-4'), 117.6 (C-5'), 127.6 (C-6'); 103.4 (C-1), 74.8 (C-2),78.4 (C-3), 71.3 (C-4), 77.5 (C-5), 62.4 (C-6).

Quercetin-3-O-β-D-xylose (QC3X), yellow powder. 1H NMR (600 MHz, CD3OD): δ 7.72 (1H, d, J = 1.9 Hz, H-2′), 7.63 (1H, dd, J = 8.5, 1.9 Hz, H-6′), 7.14 (1H, d, J = 8.7 Hz, H-5′), 6.39 (1H, brs, H-8),6.18 (1H, brs, H-6), 4.87 (1H, s, H-1′), 3.96 (1H, m, H-5″), 3.60 (1H, m, H-4′),3.54 (1H, m, H-2″), 3.48 (1H, m, H-3″),3.42 (1H, m, H-5″);13C-NMR (600 MHz, CD3OD) δ: 177.64 (C-4), 165.87 (C-7), 162.70 (C-5), 158.41 (C-2), 158.37 (C-9),148.11 (C-4′), 146.97 (C-3′), 138.15 (C-3), 127.82 (C-6′), 121.27 (C-1′), 117.57(C-2′), 116.73 (C-5′), 104.72 (C-10), 103.98 (C-1″), 99.46 (C-6), 94.59 (C-8), 77.36(C-3″), 74.72 (C-2″), 71.12 (C-4″), 67.17 (C-5″).

Quercetin-3-O-(6''-O-trans-p-coumaroyl)-β-D-glucoside (QC3GP), yellow powder. FAB-MS m/z: 609 [M-H]-; 1H NMR (600 MHz, CD3OD): δ7.77 (2H, d, J = 7.6 Hz, H-2'), 7.69 (1H, d, J = 8.4 Hz, H-6'), 7.16 (2H, d, J = 9.0Hz, H-5'), 6.81 (2H, t, J = 6.0 Hz, H-3''',5'''), 6.39 (1H, d, J = 1.8 Hz, H-8), 6.18 (1H, d, J = 1.8 Hz, H-6), 6.08 (1H, d, J = 15.6 Hz, H-8'''), 5.02 (1H, d, J = 7.2 Hz, H-1''), 4.35 (1H, dd, J = 2.4, 1.8 Hz, H-6''), 3.49 (2H, m, H-3'', 4''); 13C-NMR (600 MHz, CD3OD): δ177.65 (C-4), 168.92 (C-9'''), 166.09 (C-7), 163.12 (C-5), 161.68 (C-4'), 161.34(C-4'''), 159.46 (C-2), 158.55 (C-9), 146.98 (C-7'''), 138.16 (C-3), 132.35 (C-2', 6'),130.52 (C-2''', 6'''), 126.77 (C-1'''), 121.27 (C-1'), 117.48 (C-3', 5'), 116.73 (C-3''', 5'''),114.84 (C-8'''), 104.72 (C-10), 103.44 (C-1''), 99.47 (C-6), 94.60 (C-8), 77.82 (C-3''),74.83 (C-2''), 73.10 (C-5''), 71.12 (C-4''), 67.17 (C-6'').

Quercetin (QC), yellow powder. 1H NMR (600 MHz, CD3OD): δ 7.73 (1H, d, J = 2.1 Hz, H-2'), 7.63 (1H, dd, J = 2.1, 8.5 Hz, H-6'), 6.88 (1H, d, J = 8.4 Hz, H-5'), 6.38 (1H, d, J = 2.0 Hz, H-8), 6.17 (1H, d, J = 2.0 Hz, H-6).

α-glucosidase inhibitory activity

Our study showed that all four compounds could inhibit the hydrolysis of AG. In the concentration of 0.031, 0.0781, 0.1563, 0.3125, 0.625, 1.25 and 2.5 mg/mL-1, the inhibition rate gradually increased with the increase of concentration. The inhibition rates were all ≥70% at the maximum concentration, and the IC50 was 0.318, 0.082, 0.695, and 0.065 mmol/L-1. In the concentration of 0.19531, 0.3906, 0.781, 1.5625, 3.125, 6.25, and 12.5, 25 mg·mL-1, the inhibition rate of acarbose showed a dose-effect relationship with the concentration, and the IC50 was 4.509 mmol·L-1. Compared with acarbose, all four compounds had higher AG inhibitory activity [Figure 2] and [Table 1].
Table 1: Inhibitory activity of different compounds against α-glucosidase (X±SD)

Click here to view
Figure 2: AG inhibition rate curve of each compound

Click here to view

α-glucosidase inhibitory type

To examine the inhibitory mechanism of P. bifurca compounds, the AGI type of four compounds of P. bifurca was determined. Vm is the reaction rate at which the enzyme is completely saturated with the substrate. The Km value is equal to the substrate concentration at which the enzymatic reaction rate is half the maximum rate. The Km value of the competitive inhibitor varies with the concentration, while the Vm value remains the same. The Km value of the non-competitive inhibitor did not change with the concentration, but the Vm value decreased. The Vm of compounds QC3G, QC3X, QC3GP remained unchanged; the Km increased with the increase of concentration and conformed to the reaction characteristics of competitive inhibitors. Km of compound QC increased with compound concentration and the Vm gradually decreased. Thus compounds QC3G, QC3X, QC3GP were competitive inhibitor types, and QC was a typical non-competitive inhibitor type [Figure 3] and [Table 2].
Figure 3: Double reciprocal curves of four compounds

Click here to view
Table 2: Enzyme inhibitor types of four compounds

Click here to view

   Discussion Top

Quercetin, a strong antioxidant, possesses anti-oxidative, anti-inflammatory, anti-aggregatory, anti-cancer, and anti-vasodilation effects.[12] Several studies show that quercetin can attenuate diabetes.[13],[14] Based on the hypoglycemic activity of quercetin, the effect of the structural difference of quercetin and its derivatives on the inhibitory activity of α-glycosidase was studied. QC compared with QC3X, the hydroxy of position 3 was replaced by penta-glycoside and the hydroxyl shifted from 3' position to 5' position. QC compared with QC3G, the hydroxy of position 3 was replaced by hexose, and the hydroxyl shifted from 3' position to 5' position. QC compared with QC3GP, the hydroxy of position 3 was replaced by hexose, and the hydroxyl shifted from 3' position to 5' position. Our study showed that the inhibitory activity of α-glycosidase has some relationship with the glycosyl and acyl substitution of flavonoids. In the in vitro assay of inhibitory activity on α-glucosidase, QC showed the highest efficacy as inhibitors of α-glucosidase activity, QC3X showed higher efficacy as inhibitors of α-glucosidase activity, QC3G and QC3GP showed lower than QC and QC3X [Table 2]. Although the position of quercetin and its derivatives 3 and 5 were different, we suspected that this difference did not affect quercetin activity. The substituents of different compounds may affect the activity of flavonoids. Quercetin glycosylation can lead to the decrease of hypoglycemic activity, and the compound after adding penta-glycoside is larger than that after adding hexa-glycoside. In addition, the acylation of compounds can reduce the activity of the original compounds.

   Conclusion Top

Overall, the compounds from P. bifurca were found as potent α-glucosidase inhibitors, and QC exhibited the strongest inhibitory activity on α-glucosidase. This study suggested that quercetin and quercetin derivatives are the suitable lead compounds for designing new patent α-glucosidase inhibitors of this kind.

Financial support and sponsorship

This work was supported by the Natural Science Foundation of Qinghai Province (2020-ZJ-918), the Innovative Team of Comprehensive Utilization and Development of Medicinal Plant Resources (2020–2023), and the Key Laboratory of Qinghai Province on Plant and Animal Resources in Tibetan Plateau (2020-ZJ-Y40).

Conflicts of interest

There are no conflicts of interest.

   References Top

Han S, Shi S, Zou Y, Wang Z, Wang Y, Shi L, et al. Chemical constituents from acid hydrolyzates of panax quinquefolius total saponins and their inhibition activity to α-glycosidase and protein tyrosine phosphatase 1B. Chin Herb Med 2020;12:195-9.  Back to cited text no. 1
Deng N, Zheng B, Li T, Liu RH. Assessment of the phenolic profiles, hypoglycemic activity, and molecular mechanism of different Highland barley (Hordeum vulgare L.) varieties. Int J Mol Sci 2020;21. doi: 10.3390/ijms21041175.  Back to cited text no. 2
Compain P. Multivalent effect in glycosidase inhibition: The end of the beginning. Chem Rec 2020;20:10-22.  Back to cited text no. 3
Wang H, Wang J, Liu Y, Ji Y, Guo Y, Zhao J. Interaction mechanism of carnosic acid against glycosidase (α-amylase and α-glucosidase). Int J Biol Macromol 2019;138:846-53.  Back to cited text no. 4
Daub CD, Mabate B, Malgas S, Pletschke BI. Fucoidan from Ecklonia maxima is a powerful inhibitor of the diabetes-related enzyme, α-glucosidase. Int J Biol Macromol 2020;151:412-20.  Back to cited text no. 5
Ahn JH, Park Y, Yeon SW, Jo YH, Han YK, Turk A, et al. Phenylpropanoid-conjugated triterpenoids from the Leaves of Actinidia arguta and their inhibitory activity on α-glucosidase. J Nat Prod 2020;83:1416-23.  Back to cited text no. 6
Zhong Y, Yu L, He Q, Zhu Q, Zhang C, Cui X, et al. Bifunctional hybrid enzyme-catalytic metal organic framework reactors for α-glucosidase inhibitor screening. ACS Appl Mater Interfaces 2019;11:32769-77.  Back to cited text no. 7
Demir Y, Taslimi P, Koçyiğit ÜM, Akkuş M, Özaslan MS, Duran HE, et al. Determination of the inhibition profiles of pyrazolyl-thiazole derivatives against aldose reductase and α-glycosidase and molecular docking studies. Arch Pharm (Weinheim) 2020;353:e2000118.  Back to cited text no. 8
Chen JG, Wu SF, Zhang QF, Yin ZP, Zhang L. α-glucosidase inhibitory effect of anthocyanins from Cinnamomum camphora fruit: Inhibition kinetics and mechanistic insights through in vitro and in silico studies. Int J Biol Macromol 2020;143:696-703.  Back to cited text no. 9
Fernandes ACF, Santana ÁL, Martins IM, Moreira DKT, Macedo JA, Macedo GA. Anti-glycation effect and the α-amylase, lipase, and α-glycosidase inhibition properties of a polyphenolic fraction derived from citrus wastes. Prep Biochem Biotechnol 2020;50:794-802.  Back to cited text no. 10
Samatadze TE, Zoshchuk SA, Khomik AS, Amosova AV, Svistunova NY, Suslina SN, et al. Molecular cytogenetic characterization, leaf anatomy and ultrastructure of the medicinal plant Potentilla alba L. Genet Resour Crop Evol 2018;65:1637-47.  Back to cited text no. 11
Shree A. Quercetin modulates oxidative stress and inflammation in 1,2-dimethylhydrazine treated Wistar rats. Free Radic Biol Med 2017;112. doi: 10.1016/j.freeradbiomed. 2017.10.150.  Back to cited text no. 12
Elbe H, Vardi N, Esrefoglu M, Ates B, Yologlu S, Taskapan C. Amelioration of streptozotocin-induced diabetic nephropathy by melatonin, quercetin, and resveratrol in rats. Hum Exp Toxicol 2015;34:100-13.  Back to cited text no. 13
de Souza SR, de Miranda Neto MH, Martins Perles JV, Vieira Frez FC, Zignani I, Ramalho FV, et al. Antioxidant effects of the quercetin in the jejunal myenteric innervation of diabetic rats. Front Med (Lausanne) 2017;4:8. doi: 10.3389/fmed. 2017.00008.  Back to cited text no. 14


  [Figure 1], [Figure 2], [Figure 3]

  [Table 1], [Table 2]


    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

  In this article
    Materials and Me...
    Article Figures
    Article Tables

 Article Access Statistics
    PDF Downloaded21    
    Comments [Add]    

Recommend this journal